ClearPoint Neuro, Inc. (CLPT) Income Statement
CLPT 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsCLPT revenue and net income
Where CLPT's revenue goes
2025Each bar shows an amount and its share of revenue. CLPT kept −69.1% of revenue as net income.
CLPT profit margins
CLPT growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +17.8% | +21.6% | +23.6% | +23.2% |
| Gross profit | +18.7% | +18.8% | +20.0% | +24.2% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CLPT quarterly EPS vs estimates
ClearPoint Neuro beat the analyst EPS estimate in 0 of the last 8 quarters. Next report: October 28, 2026 (estimate $-0.27).
CLPT income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37.0M | $31.4M | $24.0M | $20.6M | $16.3M | $12.8M | $11.2M | $7.4M | $7.4M | $5.7M |
| Cost of revenue | $14.3M | $12.3M | $10.3M | $7.0M | $5.2M | $3.7M | $3.9M | $2.4M | $2.9M | $2.6M |
| Gross profit | $22.7M | $19.1M | $13.6M | $13.5M | $11.1M | $9.1M | $7.3M | $4.9M | $4.5M | $3.1M |
| Research & development | $13.9M | $12.4M | $11.7M | $10.9M | $9.3M | $4.7M | $2.8M | $2.3M | $2.8M | $2.6M |
| Sales, general & admin | $33.0M | $26.5M | $24.4M | $19.0M | $15.2M | $10.7M | $9.1M | $7.9M | $8.0M | $8.0M |
| Total operating expenses | $46.9M | $38.9M | $36.1M | $29.9M | $24.5M | $15.3M | $11.9M | $10.2M | $10.8M | $10.6M |
| Operating income | −$24.2M | −$19.7M | −$22.4M | −$16.3M | −$13.4M | −$6.2M | −$4.6M | −$5.2M | −$6.3M | −$7.5M |
| Interest income | $1.2M | $872,000 | $386,000 | — | — | — | $955,170 | $916,060 | $848,200 | $8,807 |
| Interest expense | $2.4M | $518,000 | $386,000 | $81,000 | $973,000 | $1.4M | $955,000 | $980,383 | $872,926 | $1.1M |
| Income before taxes | −$25.5M | −$18.9M | −$22.1M | −$16.4M | −$14.4M | −$6.8M | −$5.5M | −$6.2M | −$7.2M | −$8.1M |
| Income taxes | $55,000 | −$18.9M | $1.3M | $103,000 | $910,000 | $2.3M | $964,220 | $64,682 | $889,608 | $1.3M |
| Net income | −$25.5M | −$18.9M | −$22.1M | −$16.4M | −$14.4M | −$6.8M | −$5.5M | −$6.2M | −$7.2M | −$8.1M |
| EBITDA | −$20.9M | −$17.0M | −$20.6M | −$15.6M | −$12.7M | −$4.8M | −$4.3M | −$5.1M | −$6.2M | −$6.9M |
| EPS (diluted) | −$0.91 | −$0.70 | −$0.91 | −$0.68 | −$0.68 | −$0.42 | −$0.43 | −$0.56 | −$1.12 | −$3.05 |
| Gross margin | 61.4% | 60.9% | 56.8% | 65.8% | 68.2% | 71.1% | 64.9% | 66.9% | 60.7% | 54.0% |
| Operating margin | −65.4% | −62.9% | −93.7% | −79.5% | −82.1% | −48.5% | −41.0% | −71.4% | −85.9% | −130.3% |
| Net margin | −69.1% | −60.3% | −92.2% | −80.0% | −88.4% | −52.9% | −49.4% | −83.8% | −97.1% | −140.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.9M | $12.1M | $10.4M | $8.9M | $9.2M | $8.5M | $7.8M | $8.1M | $7.9M | $7.6M | $6.8M | $5.8M |
| Cost of revenue | $4.0M | $4.6M | $4.0M | $3.3M | $3.7M | $3.4M | $3.0M | $3.3M | $2.9M | $3.1M | $2.8M | $2.5M |
| Gross profit | $6.9M | $7.5M | $6.4M | $5.6M | $5.6M | $5.1M | $4.8M | $4.8M | $5.0M | $4.5M | $4.0M | $3.3M |
| Research & development | $4.6M | $4.5M | $3.2M | $3.5M | $3.8M | $3.4M | $3.3M | $3.3M | $3.1M | $2.6M | $2.7M | $2.4M |
| Sales, general & admin | $12.3M | $11.7M | $5.8M | $7.0M | $7.4M | $7.9M | $7.0M | $6.7M | $6.6M | $6.1M | $6.1M | $5.7M |
| Total operating expenses | $17.2M | $16.0M | $13.4M | $10.9M | $11.2M | $11.3M | $10.4M | $10.0M | $9.7M | $8.8M | $8.7M | $8.2M |
| Operating income | −$10.2M | −$8.5M | −$7.0M | −$5.3M | −$5.7M | −$6.2M | −$5.6M | −$5.2M | −$4.7M | −$4.2M | −$4.7M | −$4.9M |
| Interest income | $289,000 | $351,000 | — | — | $285,000 | $151,000 | $226,000 | $209,000 | $326,000 | $111,000 | — | $100,000 |
| Interest expense | $1.4M | $1.4M | $703,000 | $543,000 | $80,000 | $0 | — | — | — | — | $191,000 | — |
| Income before taxes | −$11.4M | −$9.5M | −$7.8M | −$5.9M | −$5.8M | −$6.0M | −$5.4M | −$5.0M | −$4.4M | −$4.1M | −$4.6M | −$4.8M |
| Income taxes | −$38,000 | $8,000 | $4,000 | $8,000 | $25,000 | $18,000 | −$430,724 | — | — | $15,000 | $721,000 | −$423,000 |
| Net income | −$11.3M | −$9.6M | −$7.8M | −$5.9M | −$5.8M | −$6.0M | −$5.4M | −$5.0M | −$4.4M | −$4.1M | −$4.6M | −$4.8M |
| EBITDA | −$8.9M | −$7.0M | −$6.2M | −$4.9M | −$5.1M | −$5.7M | −$4.9M | −$4.5M | −$3.9M | −$3.7M | −$4.2M | −$4.4M |
| EPS (diluted) | −$0.38 | −$0.32 | −$0.27 | −$0.21 | −$0.21 | −$0.22 | −$0.20 | −$0.18 | −$0.16 | −$0.16 | −$0.19 | −$0.20 |
| Gross margin | 63.6% | 62.2% | 61.5% | 63.2% | 60.3% | 60.5% | 61.3% | 59.7% | 63.5% | 59.2% | 58.9% | 56.8% |
| Operating margin | −94.2% | −69.9% | −67.7% | −59.5% | −61.6% | −72.6% | −72.1% | −63.7% | −60.3% | −55.4% | −69.1% | −85.0% |
| Net margin | −104.2% | −78.8% | −74.8% | −66.5% | −63.3% | −71.0% | −69.3% | −61.2% | −56.1% | −54.3% | −67.8% | −83.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CLPT's financial statements (latest annual report filed March 17, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CLPT financial results
In fiscal year 2025 (ended December 31, 2025), ClearPoint Neuro reported revenue of $37.0 million, up 17.8% from the year before. It had a net loss of $25.5 million, a net profit margin of −69.1%. Diluted earnings per share came to −$0.91. Over five years revenue grew at an average rate of 23.6% a year.
See the CLPT stock overview for the latest quote and news, or the CLPT chart for price history and technical indicators.
CLPT income statement FAQ
What is ClearPoint Neuro's annual revenue?
ClearPoint Neuro reported total revenue of $37.0 million for fiscal year 2025, which ended on December 31, 2025. That was up 17.8% from $31.4 million the previous year.
Is ClearPoint Neuro profitable?
No. ClearPoint Neuro reported a net loss of $25.5 million in fiscal 2025, a net profit margin of −69.1%; its operating margin was −65.4%.
What is ClearPoint Neuro's gross margin?
ClearPoint Neuro's gross margin was 61.4% in fiscal 2025: for every $100 of revenue, ClearPoint Neuro kept $61 after the direct cost of its products and services.
How much does ClearPoint Neuro spend on research and development?
ClearPoint Neuro spent $13.9 million on research and development in fiscal 2025, 37.6% of revenue.
How fast is ClearPoint Neuro growing?
Revenue grew 23.6% a year on average over the last five fiscal years, from $12.8 million to $37.0 million.
What are ClearPoint Neuro's earnings per share?
ClearPoint Neuro earned $-0.91 per diluted share in fiscal 2025, compared with $-0.70 a year earlier.
When will ClearPoint Neuro report its next earnings?
ClearPoint Neuro is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 after the market closes.
When does ClearPoint Neuro's fiscal year end?
ClearPoint Neuro's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 17, 2026.